2017-2022 Global and Japan Blood system drugs Market Analysis Report

Published: Aug, 2017 | Pages: 127 | Publisher: JP Research
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)

The global Blood system drugs market is valued at XX million USD in 2016 and is expected to reach XX million USD by the end of 2017, growing at a CAGR of XX% between 2016 and 2022.

Japan plays an important role in global market, with market size of xx million USD in 2016 and will be xx million USD in 2017, with a CAGR of xx%.

This report, with focus on top players in the global and Japan, studies the Blood system drugs market's development status and future trend in the global and Japan. It splits Blood system drugs market by type and by applications to fully and deeply research and reveal market profile and prospect.

The major players include
    ACTAVIS ELIZABETH
    AKORN
    ALLERGAN SALES LLC
    AMNEAL PHARMS
    APOTEX
    ARALEZ PHARMS
    ASTRAZENECA PHARMS
    AVEDRO INC
    BARR
    BAXTER HLTHCARE
    BIOKEY
    BRECKENRIDGE PHARM
    BRISTOL MYERS SQUIBB
    CHIESI USA INC
    CLOVER PHARMS
    EMCURE PHARMS LTD
    FERRING PHARMS INC
    FRESENIUS KABI USA
    GENENTECH
    GLAND PHARMA LTD
    GLENMARK PHARMS LTD
    HERITAGE PHARMA
    HOSPIRA
    INVAGEN PHARMS
    IPCA LABS LTD
    LUITPOLD
    MEDICURE
    MYLAN
    NEW RIVER
    PFIZER

Geographically, this report splits the Global market into the following regions:
    Asia Pacific
        Japan
            Tokyo
            Yokohama
            Osaka
            Nagoya
            Others
        China
        Korea
        India
        Others
    Europe
        France
        Germany
        United Kingdom
        Italy
        Russia
        Others
    North America
        United States
        Canada
    Latin America
        Brazil
        Mexico
        Others
    Southeast Asia
        Singapore
        Malaysia
        Vietnam
        Myanmar
        Thailand
        Indonesia
        Philippines
        Others
    Middle East & Africa
        Saudi Arabia
        Iran
        UAE
        Turkey
        Israel
        Egypt
        South Africa
        Others

On the basis of product, the Blood system drugs market is primarily split into
Blood system drugs Market, by Antianemic Agents
    Ferrous sulfate
    Ferrous succinate
    RHUEPO
    Irondextrin
    Vitamin B12
    Folic acid
    Mecobalamin
    Cobamamide
    Epogen/Procrit
    NeoRecormon
    Dynepo
    Eporatio/Biopoin
    Aranesp/NESP
    Mircera/CERA
    Binocrit
    Abseamed
    Epoetin Alfa Hexal
    Retacrit/Silapo
Blood system drugs Market, by Antiplatelet drug
    Aspirin
    Dipyridamole
    Clopidogrel
    Prasugrel
    Ticagrelor
    Glycoprotein
    Aggrastat
    Cilostazol
    Ticlopidine
    Cangrelor
    Vorapaxar
    Atopaxar
    Sarpogrelate
Blood system drugs Market, by Coagulant Drugs
    Thrombin
    Etamsylate
    Menadione Sodium Bisulfite
    Vitamin K1
    Aminomethylbenzoic Acid
    Desmopressin acetate
    Human Coagulation Factor
    Prothrombin Complex
    Artificial fibrinogen
    Aminomethylbenzoic Acid
    Tranexamic acid
    Aprotinin
    Aminocaproic Acid
    Carbazochrome
    Pituitrin
Blood system drugs Market, by Anticoagulant and thrombolyti
    heparin
    urokinase
    Warfarin
    Bishydroxycoumarin
    Streptokinase
    Silteplase
Blood system drugs Market, by blood volume expander
    Hydroxyethyl starch 40
    Dextran
    Polyglucose

Key Applications
    department of hematology
    Internal Medicine
    department of surgery
    Pharmacy
    Hospital

 Table of Contents

2017-2022 Global and Japan Blood system drugs Market Analysis Report
1 Blood system drugs Overview
    1.1 Product Overview and Scope of Blood system drugs
    1.2 Global and Japan Blood system drugs Market by Applications/End Users
        1.2.1 Japan Blood system drugs Sales () and Market Share Comparison by Applications (2012-2017)
            1.2.1.1 Japan Blood system drugs Sales () and Market Share by Applications (2012-2017)
            1.2.1.2 Japan Blood system drugs Sales Growth Rate (%) by Applications (2012-2017)
            1.2.1.3 Market Drivers and Opportunities
        1.2.2 Japan Blood system drugs Sales () and Market Share Comparison by Applications (2012-2017)
        1.2.3 Global Blood system drugs Sales by Application (2012-2017)
            1.2.3.1 Global Blood system drugs Sales () and Market Share by Applications (2012-2017)
            1.2.3.2 Global Blood system drugs Sales Growth Rate (%) by Applications (2012-2017)
            1.2.3.3 Market Drivers and Opportunities
        1.2.4 Global Blood system drugs Sales () and Market Share Comparison by Applications (2012-2017)
        1.2.5 department of hematology
        1.2.6 Internal Medicine
        1.2.7 department of surgery
        1.2.8 Pharmacy
        1.2.9 Hospital
    1.3 Global and Japan Market Size (Sales and Revenue) of Blood system drugs (2012-2017)
        1.3.1 Japan Market Size (Sales and Revenue) of Blood system drugs (2012-2017)
            1.3.1.1 Japan Blood system drugs Sales () and Growth Rate (%) (2012-2017)
            1.3.1.2 Japan Blood system drugs Revenue (Million USD) and Growth Rate (2012-2017)
        1.3.2 Global Market Size (Sales and Revenue) of Blood system drugs (2012-2017)
            1.3.2.1 Global Blood system drugs Sales () and Growth Rate (%) (2012-2017)
            1.3.2.2 Global Blood system drugs Revenue (Million USD) and Growth Rate (2012-2017)
    1.4 Global and Japan Classification of Blood system drugs by Antianemic Agents
        1.4.1 Japan Blood system drugs Sales () and Market Share by Antianemic Agents (2012-2017)
        1.4.2 Global Blood system drugs Sales () and Market Share by Antianemic Agents (2012-2017)
        1.4.3 Japan Blood system drugs Revenue (Million USD) and Market Share by Antianemic Agents (2012-2017)
        1.4.4 Global Blood system drugs Revenue (Million USD) and Market Share by Antianemic Agents (2012-2017)
        1.4.5 Japan Blood system drugs Price () by Antianemic Agents (2012-2017)
        1.4.6 Global Blood system drugs Price () by Antianemic Agents (2012-2017)
        1.4.7 Japan Blood system drugs Sales Growth Rate (%) by Antianemic Agents (2012-2017)
        1.4.8 Global Blood system drugs Sales Growth Rate (%) by Antianemic Agents (2012-2017)
        1.4.9 Ferrous sulfate
        1.4.10 Ferrous succinate
        1.4.11 RHUEPO
        1.4.12 Iron-dextrin
        1.4.13 Vitamin B12
        1.4.14 Folic acid
        1.4.15 Mecobalamin
        1.4.16 Cobamamide
    1.5 Global and Japan Classification of Blood system drugs by Antiplatelet drug
        1.5.1 Japan Blood system drugs Sales () and Market Share by Antiplatelet drug (2012-2017)
        1.5.2 Global Blood system drugs Sales () and Market Share by Antiplatelet drug (2012-2017)
        1.5.3 Japan Blood system drugs Revenue (Million USD) and Market Share by Antiplatelet drug (2012-2017)
        1.5.4 Global Blood system drugs Revenue (Million USD) and Market Share by Antiplatelet drug (2012-2017)
        1.5.5 Japan Blood system drugs Price () by Antiplatelet drug (2012-2017)
        1.5.6 Global Blood system drugs Price () by Antiplatelet drug (2012-2017)
        1.5.7 Japan Blood system drugs Sales Growth Rate (%) by Antiplatelet drug (2012-2017)
        1.5.8 Global Blood system drugs Sales Growth Rate (%) by Antiplatelet drug (2012-2017)
        1.5.9 Aspirin
        1.5.10 Dipyridamole
        1.5.11 Clopidogrel
        1.5.12 Prasugrel
        1.5.13 Ticagrelor
        1.5.14 Cangrelor
        1.5.15 Vorapaxar
        1.5.16 Atopaxar
        1.5.17 Sarpogrelate
    1.6 Global and Japan Classification of Blood system drugs by Coagulant Drugs
        1.6.1 Japan Blood system drugs Sales () and Market Share by Coagulant Drugs (2012-2017)
        1.6.2 Global Blood system drugs Sales () and Market Share by Coagulant Drugs (2012-2017)
        1.6.3 Japan Blood system drugs Revenue (Million USD) and Market Share by Coagulant Drugs (2012-2017)
        1.6.4 Global Blood system drugs Revenue (Million USD) and Market Share by Coagulant Drugs (2012-2017)
        1.6.5 Japan Blood system drugs Price () by Coagulant Drugs (2012-2017)
        1.6.6 Global Blood system drugs Price () by Coagulant Drugs (2012-2017)
        1.6.7 Japan Blood system drugs Sales Growth Rate (%) by Coagulant Drugs (2012-2017)
        1.6.8 Global Blood system drugs Sales Growth Rate (%) by Coagulant Drugs (2012-2017)
        1.6.9 Thrombin
        1.6.10 Etamsylate
        1.6.11 Menadione Sodium Bisulfite
        1.6.12 Vitamin K1
        1.6.13 Aminomethylbenzoic Acid
        1.6.14 Desmopressin acetate
        1.6.15 Human Coagulation Factor
        1.6.16 Prothrombin Complex
        1.6.17 Artificial fibrinogen
        1.6.18 Aminomethylbenzoic Acid
        1.6.19 Tranexamic acid
        1.6.20 Aprotinin
        1.6.21 Aminocaproic Acid
        1.6.22 Carbazochrome
        1.6.23 Pituitrin
    1.7 Global and Japan Classification of Blood system drugs by Anticoagulant and thrombolytic
        1.7.1 Japan Blood system drugs Sales () and Market Share by Anticoagulant and thrombolytic (2012-2017)
        1.7.2 Global Blood system drugs Sales () and Market Share by Anticoagulant and thrombolytic (2012-2017)
        1.7.3 Japan Blood system drugs Revenue (Million USD) and Market Share by Anticoagulant and thrombolytic (2012-2017)
        1.7.4 Global Blood system drugs Revenue (Million USD) and Market Share by Anticoagulant and thrombolytic (2012-2017)
        1.7.5 Japan Blood system drugs Price () by Anticoagulant and thrombolytic (2012-2017)
        1.7.6 Global Blood system drugs Price () by Anticoagulant and thrombolytic (2012-2017)
        1.7.7 Japan Blood system drugs Sales Growth Rate (%) by Anticoagulant and thrombolytic (2012-2017)
        1.7.8 Global Blood system drugs Sales Growth Rate (%) by Anticoagulant and thrombolytic (2012-2017)
        1.7.9 heparin
        1.7.10 urokinase
        1.7.11 Warfarin
        1.7.12 Bishydroxycoumarin
        1.7.13 Streptokinase
        1.7.14 Silteplase
    1.8 Global and Japan Classification of Blood system drugs by blood volume expander
        1.8.1 Japan Blood system drugs Sales () and Market Share by blood volume expander (2012-2017)
        1.8.2 Global Blood system drugs Sales () and Market Share by blood volume expander (2012-2017)
        1.8.3 Japan Blood system drugs Revenue (Million USD) and Market Share by blood volume expander (2012-2017)
        1.8.4 Global Blood system drugs Revenue (Million USD) and Market Share by blood volume expander (2012-2017)
        1.8.5 Japan Blood system drugs Price () by blood volume expander (2012-2017)
        1.8.6 Global Blood system drugs Price () by blood volume expander (2012-2017)
        1.8.7 Japan Blood system drugs Sales Growth Rate (%) by blood volume expander (2012-2017)
        1.8.8 Global Blood system drugs Sales Growth Rate (%) by blood volume expander (2012-2017)
        1.8.9 Hydroxyethyl starch 40
        1.8.10 Dextran
        1.8.11 Polyglucose

2 Global and Japan Blood system drugs Market Competition by Players/Manufacturers
    2.1 Japan Blood system drugs Market Competition by Players/Manufacturers
    2.1.1 Japan Blood system drugs Sales and Market Share of Key Players/Manufacturers (2012-2017)
    2.1.2 Japan Blood system drugs Revenue and Share by Players/Manufacturers (2012-2017)
    2.1.3 Japan Blood system drugs Average Price () by Players/Manufacturers (2012-2017)
    2.1.4 Japan Blood system drugs Market Competitive Situation and Trends
        2.1.4.1 Japan Blood system drugs Market Concentration Rate
        2.1.4.2 Japan Blood system drugs Market Share of Top 3 and Top 5 Players/Manufacturers
        2.1.4.3 Mergers & Acquisitions, Expansion in Japan Market
    2.1.5 Japan Players/Manufacturers Blood system drugs Manufacturing Base Distribution, Sales Area, Product Types
    2.2 Global Blood system drugs Market Competition by Players/Manufacturers
    2.2.1 Global Blood system drugs Sales and Market Share of Key Players/Manufacturers (2012-2017)
    2.2.2 Global Blood system drugs Revenue and Share by Players/Manufacturers (2012-2017)
    2.2.3 Global Blood system drugs Average Price () by Players/Manufacturers (2012-2017)
    2.2.4 Global Blood system drugs Market Competitive Situation and Trends
        2.2.4.1 Global Blood system drugs Market Concentration Rate
        2.2.4.2 Global Blood system drugs Market Share of Top 3 and Top 5 Players/Manufacturers
        2.2.4.3 Mergers & Acquisitions, Expansion in Global Market
    2.2.5 Global Players/Manufacturers Blood system drugs Manufacturing Base Distribution, Sales Area, Product Types

3 Global and Japan Blood system drugs Sales and Revenue by Regions (2012-2017)
    3.1 Asia Pacific Blood system drugs Sales and Revenue by Regions (2012-2017)
        3.1.1 Japan Blood system drugs Sales and Revenue  (2012-2017)
            3.1.1.1 Japan Blood system drugs Sales () and Market Share  (2012-2017)
            3.1.1.2 Japan Blood system drugs Revenue (Million USD) and Market Share (2012-2017)
            3.1.1.3 Japan Blood system drugs Price ()(2012-2017)
        3.1.2 China Blood system drugs Sales and Revenue (2012-2017)
            3.1.2.1 China Blood system drugs Sales () and Market Share (2012-2017)
            3.1.2.2 China Blood system drugs Revenue (Million USD) and Market Share (2012-2017)
            3.1.2.3 China Blood system drugs Price ()(2012-2017)
        3.1.3 Korea Blood system drugs Sales and Revenue (2012-2017)
            3.1.3.1 Korea Blood system drugs Sales () and Market Share (2012-2017)
            3.1.3.2 Korea Blood system drugs Revenue (Million USD) and Market Share (2012-2017)
            3.1.3.3 Korea Blood system drugs Price ()(2012-2017)
        3.1.4 India Blood system drugs Sales and Revenue (2012-2017)
            3.1.4.1 India Blood system drugs Sales () and Market Share (2012-2017)
            3.1.4.2 India Blood system drugs Revenue (Million USD) and Market Share (2012-2017)
            3.1.4.3 India Blood system drugs Price ()(2012-2017)
        3.1.5 Others Blood system drugs Sales and Revenue (2012-2017)
            3.1.5.1 Others Blood system drugs Sales () and Market Share (2012-2017)
            3.1.5.2 Others Blood system drugs Revenue (Million USD) and Market Share (2012-2017)
            3.1.5.3 Others Blood system drugs Price ()(2012-2017)
    3.2 Europe Blood system drugs Sales and Revenue by Regions (2012-2017)
        3.2.1 France Blood system drugs Sales and Revenue (2012-2017)
            3.2.1.1 France Blood system drugs Sales () and Market Share (2012-2017)
            3.2.1.2 France Blood system drugs Revenue (Million USD) and Market Share (2012-2017)
            3.2.1.3 France Blood system drugs Price ()(2012-2017)
        3.2.2 Germany Blood system drugs Sales and Revenue (2012-2017)
            3.2.2.1 Germany Blood system drugs Sales () and Market Share (2012-2017)
            3.2.2.2 Germany Blood system drugs Revenue (Million USD) and Market Share (2012-2017)
            3.2.2.3 Germany Blood system drugs Price ()(2012-2017)
        3.2.3 United Kingdom Blood system drugs Sales and Revenue (2012-2017)
            3.2.3.1 United Kingdom Blood system drugs Sales () and Market Share (2012-2017)
            3.2.3.2 United Kingdom Blood system drugs Revenue (Million USD) and Market Share (2012-2017)
            3.2.3.3 United Kingdom Blood system drugs Price ()(2012-2017)
        3.2.4 Italy Blood system drugs Sales and Revenue (2012-2017)
            3.2.4.1 Italy Blood system drugs Sales () and Market Share (2012-2017)
            3.2.4.2 Italy Blood system drugs Revenue (Million USD) and Market Share (2012-2017)
            3.2.4.3 Italy Blood system drugs Price ()(2012-2017)
        3.2.5 Russia Blood system drugs Sales and Revenue (2012-2017)
            3.2.5.1 Russia Blood system drugs Sales () and Market Share (2012-2017)
            3.2.5.2 Russia Blood system drugs Revenue (Million USD) and Market Share (2012-2017)
            3.2.5.3 Russia Blood system drugs Price ()(2012-2017)
        3.2.6 Others Blood system drugs Sales and Revenue (2012-2017)
            3.2.6.1 Others Blood system drugs Sales () and Market Share (2012-2017)
            3.2.6.2 Others Blood system drugs Revenue (Million USD) and Market Share (2012-2017)
            3.2.6.3 Others Blood system drugs Price ()(2012-2017)
    3.3 North America Blood system drugs Sales and Revenue by Regions (2012-2017)
        3.3.1 United States Blood system drugs Sales and Revenue (2012-2017)
            3.3.1.1 United States Blood system drugs Sales () and Market Share (2012-2017)
            3.3.1.2 United States Blood system drugs Revenue (Million USD) and Market Share (2012-2017)
            3.3.1.3 United States Blood system drugs Price ()(2012-2017)
        3.3.2 Canada Blood system drugs Sales and Revenue (2012-2017)
            3.3.2.1 Canada Blood system drugs Sales () and Market Share (2012-2017)
            3.3.2.2 Canada Blood system drugs Revenue (Million USD) and Market Share (2012-2017)
            3.3.2.3 Canada Blood system drugs Price ()(2012-2017)
    3.4 Latin America Blood system drugs Sales and Revenue by Regions (2012-2017)
        3.4.1 Brazil Blood system drugs Sales and Revenue (2012-2017)
            3.4.1.1 Brazil Blood system drugs Sales () and Market Share (2012-2017)
            3.4.1.2 Brazil Blood system drugs Revenue (Million USD) and Market Share (2012-2017)
            3.4.1.3 Brazil Blood system drugs Price ()(2012-2017)
        3.4.2 Mexico Blood system drugs Sales and Revenue (2012-2017)
            3.4.2.1 Mexico Blood system drugs Sales () and Market Share (2012-2017)
            3.4.2.2 Mexico Blood system drugs Revenue (Million USD) and Market Share (2012-2017)
            3.4.2.3 Mexico Blood system drugs Price ()(2012-2017)
        3.4.3 Others Blood system drugs Sales and Revenue (2012-2017)
            3.4.3.1 Others Blood system drugs Sales () and Market Share (2012-2017)
            3.4.3.2 Others Blood system drugs Revenue (Million USD) and Market Share (2012-2017)
            3.4.3.3 Others Blood system drugs Price ()(2012-2017)
    3.5 Southeast Asia Blood system drugs Sales and Revenue by Regions (2012-2017)
        3.5.1 Singapore Blood system drugs Sales and Revenue (2012-2017)
            3.5.1.1 Singapore Blood system drugs Sales () and Market Share (2012-2017)
            3.5.1.2 Singapore Blood system drugs Revenue (Million USD) and Market Share (2012-2017)
            3.5.1.3 Singapore Blood system drugs Price ()(2012-2017)
        3.5.2 Malaysia Blood system drugs Sales and Revenue (2012-2017)
            3.5.2.1 Malaysia Blood system drugs Sales () and Market Share (2012-2017)
            3.5.2.2 Malaysia Blood system drugs Revenue (Million USD) and Market Share (2012-2017)
            3.5.2.3 Malaysia Blood system drugs Price ()(2012-2017)
        3.5.3 Vietnam Blood system drugs Sales and Revenue (2012-2017)
            3.5.3.1 Vietnam Blood system drugs Sales () and Market Share (2012-2017)
            3.5.3.2 Vietnam Blood system drugs Revenue (Million USD) and Market Share (2012-2017)
            3.5.3.3 Vietnam Blood system drugs Price ()(2012-2017)
        3.5.4 Myanmar Blood system drugs Sales and Revenue (2012-2017)
            3.5.4.1 Myanmar Blood system drugs Sales () and Market Share (2012-2017)
            3.5.4.2 Myanmar Blood system drugs Revenue (Million USD) and Market Share (2012-2017)
            3.5.4.3 Myanmar Blood system drugs Price ()(2012-2017)
        3.5.5 Thailand Blood system drugs Sales and Revenue (2012-2017)
            3.5.5.1 Thailand Blood system drugs Sales () and Market Share (2012-2017)
            3.5.5.2 Thailand Blood system drugs Revenue (Million USD) and Market Share (2012-2017)
            3.5.5.3 Thailand Blood system drugs Price ()(2012-2017)
        3.5.6 Indonesia Blood system drugs Sales and Revenue (2012-2017)
            3.5.6.1 Indonesia Blood system drugs Sales () and Market Share (2012-2017)
            3.5.6.2 Indonesia Blood system drugs Revenue (Million USD) and Market Share (2012-2017)
            3.5.6.3 Indonesia Blood system drugs Price ()(2012-2017)
        3.5.7 Philippines Blood system drugs Sales and Revenue (2012-2017)
            3.5.7.1 Philippines Blood system drugs Sales () and Market Share (2012-2017)
            3.5.7.2 Philippines Blood system drugs Revenue (Million USD) and Market Share (2012-2017)
            3.5.7.3 Philippines Blood system drugs Price ()(2012-2017)
        3.5.8 Others Blood system drugs Sales and Revenue (2012-2017)
            3.5.8.1 Others Blood system drugs Sales () and Market Share (2012-2017)
            3.5.8.2 Others Blood system drugs Revenue (Million USD) and Market Share (2012-2017)
            3.5.8.3 Others Blood system drugs Price ()(2012-2017)
    3.6 Middle East & Africa Blood system drugs Sales and Revenue by Regions (2012-2017)
        3.6.1 Saudi Arabia Blood system drugs Sales and Revenue (2012-2017)
            3.6.1.1 Saudi Arabia Blood system drugs Sales () and Market Share (2012-2017)
            3.6.1.2 Saudi Arabia Blood system drugs Revenue (Million USD) and Market Share (2012-2017)
            3.6.1.3 Saudi Arabia Blood system drugs Price ()(2012-2017)
        3.6.2 Iran Blood system drugs Sales and Revenue (2012-2017)
            3.6.2.1 Iran Blood system drugs Sales () and Market Share (2012-2017)
            3.6.2.2 Iran Blood system drugs Revenue (Million USD) and Market Share (2012-2017)
            3.6.2.3 Iran Blood system drugs Price ()(2012-2017)
        3.6.3 UAE Blood system drugs Sales and Revenue (2012-2017)
            3.6.3.1 UAE Blood system drugs Sales () and Market Share (2012-2017)
            3.6.3.2 UAE Blood system drugs Revenue (Million USD) and Market Share (2012-2017)
            3.6.3.3 UAE Blood system drugs Price ()(2012-2017)
        3.6.4 Turkey Blood system drugs Sales and Revenue (2012-2017)
            3.6.4.1 Turkey Blood system drugs Sales () and Market Share (2012-2017)
            3.6.4.2 Turkey Blood system drugs Revenue (Million USD) and Market Share (2012-2017)
            3.6.4.3 Turkey Blood system drugs Price ()(2012-2017)
        3.6.5 Israel Blood system drugs Sales and Revenue (2012-2017)
            3.6.5.1 Israel Blood system drugs Sales () and Market Share (2012-2017)
            3.6.5.2 Israel Blood system drugs Revenue (Million USD) and Market Share (2012-2017)
            3.6.5.3 Israel Blood system drugs Price ()(2012-2017)
        3.6.6 Egypt Blood system drugs Sales and Revenue (2012-2017)
            3.6.6.1 Egypt Blood system drugs Sales () and Market Share (2012-2017)
            3.6.6.2 Egypt Blood system drugs Revenue (Million USD) and Market Share (2012-2017)
            3.6.6.3 Egypt Blood system drugs Price ()(2012-2017)
        3.6.7 South Africa Blood system drugs Sales and Revenue (2012-2017)
            3.6.7.1 South Africa Blood system drugs Sales () and Market Share (2012-2017)
            3.6.7.2 South Africa Blood system drugs Revenue (Million USD) and Market Share (2012-2017)
            3.6.7.3 South Africa Blood system drugs Price ()(2012-2017)
        3.6.8 Others Blood system drugs Sales and Revenue (2012-2017)
            3.6.8.1 Others Blood system drugs Sales () and Market Share (2012-2017)
            3.6.8.2 Others Blood system drugs Revenue (Million USD) and Market Share (2012-2017)
            3.6.8.3 Others Blood system drugs Price ()(2012-2017)

4 Global and Japan Blood system drugs Players/Manufacturers Profiles and Sales Data
    4.1 ACTAVIS ELIZABETH
        4.1.1 Company Basic Information, Manufacturing Base and Competitors
        4.1.2 Blood system drugs Product Category, Application and Specification
            4.1.2.1 Product A
            4.1.2.2 Product B
        4.1.3 ACTAVIS ELIZABETH Blood system drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
        4.1.4 Main Business/Business Overview
    4.2 AKORN
        4.2.1 Company Basic Information, Manufacturing Base and Competitors
        4.2.2 Blood system drugs Product Category, Application and Specification
            4.2.2.1 Product A
            4.2.2.2 Product B
        4.2.3 AKORN Blood system drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
        4.2.4 Main Business/Business Overview
    4.3 ALLERGAN SALES LLC
        4.3.1 Company Basic Information, Manufacturing Base and Competitors
        4.3.2 Blood system drugs Product Category, Application and Specification
            4.3.2.1 Product A
            4.3.2.2 Product B
        4.3.3 ALLERGAN SALES LLC Blood system drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
        4.3.4 Main Business/Business Overview
    4.4 AMNEAL PHARMS
        4.4.1 Company Basic Information, Manufacturing Base and Competitors
        4.4.2 Blood system drugs Product Category, Application and Specification
            4.4.2.1 Product A
            4.4.2.2 Product B
        4.4.3 AMNEAL PHARMS Blood system drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
        4.4.4 Main Business/Business Overview
    4.5 APOTEX
        4.5.1 Company Basic Information, Manufacturing Base and Competitors
        4.5.2 Blood system drugs Product Category, Application and Specification
            4.5.2.1 Product A
            4.5.2.2 Product B
        4.5.3 APOTEX Blood system drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
        4.5.4 Main Business/Business Overview
    4.6 ARALEZ PHARMS
        4.6.1 Company Basic Information, Manufacturing Base and Competitors
        4.6.2 Blood system drugs Product Category, Application and Specification
            4.6.2.1 Product A
            4.6.2.2 Product B
        4.6.3 ARALEZ PHARMS Blood system drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
        4.6.4 Main Business/Business Overview
    4.7 ASTRAZENECA PHARMS
        4.7.1 Company Basic Information, Manufacturing Base and Competitors
        4.7.2 Blood system drugs Product Category, Application and Specification
            4.7.2.1 Product A
            4.7.2.2 Product B
        4.7.3 ASTRAZENECA PHARMS Blood system drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
        4.7.4 Main Business/Business Overview
    4.8 AVEDRO INC
        4.8.1 Company Basic Information, Manufacturing Base and Competitors
        4.8.2 Blood system drugs Product Category, Application and Specification
            4.8.2.1 Product A
            4.8.2.2 Product B
        4.8.3 AVEDRO INC Blood system drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
        4.8.4 Main Business/Business Overview
    4.9 BARR
        4.9.1 Company Basic Information, Manufacturing Base and Competitors
        4.9.2 Blood system drugs Product Category, Application and Specification
            4.9.2.1 Product A
            4.9.2.2 Product B
        4.9.3 BARR Blood system drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
        4.9.4 Main Business/Business Overview
    4.10 BAXTER HLTHCARE
        4.10.1 Company Basic Information, Manufacturing Base and Competitors
        4.10.2 Blood system drugs Product Category, Application and Specification
            4.10.2.1 Product A
            4.10.2.2 Product B
        4.10.3 BAXTER HLTHCARE Blood system drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
        4.10.4 Main Business/Business Overview
    4.11 BIOKEY
    4.12 BRECKENRIDGE PHARM
    4.13 BRISTOL MYERS SQUIBB
    4.14 CHIESI USA INC
    4.15 CLOVER PHARMS
    4.16 EMCURE PHARMS LTD
    4.17 FERRING PHARMS INC
    4.18 FRESENIUS KABI USA
    4.19 GENENTECH
    4.20 GLAND PHARMA LTD
    4.21 GLENMARK PHARMS LTD
    4.22 HERITAGE PHARMA
    4.23 HOSPIRA
    4.24 INVAGEN PHARMS
    4.25 IPCA LABS LTD
    4.26 LUITPOLD
    4.27 MEDICURE
    4.28 MYLAN
    4.29 NEW RIVER
    4.30 PFIZER

5 Blood system drugs Manufacturing Cost Analysis
    5.1 Blood system drugs Key Raw Materials Analysis
        5.1.1 Key Raw Materials
        5.1.2 Price Trend of Key Raw Materials
        5.1.3 Key Suppliers of Raw Materials
        5.1.4 Market Concentration Rate of Raw Materials
    5.2 Proportion of Manufacturing Cost Structure
        5.2.1 Raw Materials
        5.2.2 Labor Cost
        5.2.3 Manufacturing Expenses
    5.3 Manufacturing Process Analysis of Blood system drugs

6 Industrial Chain, Sourcing Strategy and Downstream Buyers
    6.1 Blood system drugs Industrial Chain Analysis
    6.2 Upstream Raw Materials Sourcing
    6.3 Raw Materials Sources of Blood system drugs Major Players/Manufacturers in 2016
    6.4 Downstream Buyers

7 Marketing Strategy Analysis, Distributors/Traders
    7.1 Marketing Channel
        7.1.1 Direct Marketing
        7.1.2 Indirect Marketing
        7.1.3 Marketing Channel Development Trend
    7.2 Market Positioning
        7.2.1 Pricing Strategy
        7.2.2 Brand Strategy
        7.2.3 Target Client
    7.3 Distributors/Traders List

8 Market Effect Factors Analysis
    8.1 Technology Progress/Risk
        8.1.1 Substitutes Threat
        8.1.2 Technology Progress in Related Industry
    8.2 Consumer Needs/Customer Preference Change
    8.3 Economic/Political Environmental Change

9 Global and Japan Blood system drugs Market Size (Sales and Revenue) Forecast (2017-2022)
    9.1 Global and Japan Blood system drugs Sales (), Revenue (Million USD) Forecast (2017-2022)
    9.2 Global and Japan Blood system drugs Sales () Forecast by Type (2017-2022)
        9.2.1 by Antianemic Agents
        9.2.2 by Antiplatelet drug
        9.2.3 by Coagulant Drugs
        9.2.4 by Anticoagulant and thrombolytic
        9.2.5 by blood volume expander
    9.3 Global and Japan Blood system drugs Sales () Forecast by Application (2017-2022)
    9.4 Global and Japan Blood system drugs Sales () Forecast by Regions (2017-2022)

10 Research Findings and Conclusion

11 Methodology and Data Source
    11.1 Methodology/Research Approach
        11.1.1 Research Programs/Design
        11.1.2 Market Size Estimation
        11.1.3 Market Breakdown and Data Triangulation
    11.2 Data Source
        11.2.1 Secondary Sources
        11.2.2 Primary Sources
    11.3 Disclaimer
    11.4 Author List

List of Tables and Figures

    Figure Product Picture of Blood system drugs
    Table Japan Blood system drugs Sales (Million Units) Comparison by Applications (2012-2017)
    Figure Japan Sales Market Share (%) of Blood system drugs by Applications in 2016
    Table Global Blood system drugs Sales (Million Units) Comparison by Applications (2012-2017)
    Figure Global Sales Market Share (%) of Blood system drugs by Applications in 2016
    Figure department of hematology Examples
    Table Key Downstream Customer in department of hematology
    Figure Internal Medicine Examples
    Table Key Downstream Customer in Internal Medicine
    Figure department of surgery Examples
    Table Key Downstream Customer in department of surgery
    Figure Pharmacy Examples
    Table Key Downstream Customer in Pharmacy
    Figure Hospital Examples
    Table Key Downstream Customer in Hospital
    Figure Ferrous sulfate Product Picture
    Figure Ferrous succinate Product Picture
    Figure RHUEPO Product Picture
    Figure Iron-dextrin Product Picture
    Figure Vitamin B12 Product Picture
    Figure Aspirin Product Picture
    Figure Dipyridamole Product Picture
    Figure Clopidogrel Product Picture
    Figure Prasugrel Product Picture
    Figure Ticagrelor Product Picture
    Figure Thrombin Product Picture
    Figure Etamsylate Product Picture
    Figure Menadione Sodium Bisulfite Product Picture
    Figure Vitamin K1 Product Picture
    Figure Aminomethylbenzoic Acid Product Picture
    Figure heparin Product Picture
    Figure urokinase Product Picture
    Figure Warfarin Product Picture
    Figure Bishydroxycoumarin Product Picture
    Figure Streptokinase Product Picture
    Figure Dextran Product Picture
    Figure Polyglucose Product Picture
    Table ACTAVIS ELIZABETH Basic Information List
    Table ACTAVIS ELIZABETH Blood system drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
    Table ACTAVIS ELIZABETH Blood system drugs Sales Growth Rate (%)(2012-2017)
    Table ACTAVIS ELIZABETH Blood system drugs Sales Market Share (%) in Japan (2012-2017)
    Figure ACTAVIS ELIZABETH Blood system drugs Revenue Market Share (%) in Japan (2012-2017)
    Table AKORN Basic Information List
    Table AKORN Blood system drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
    Table AKORN Blood system drugs Sales Growth Rate (%)(2012-2017)
    Table AKORN Blood system drugs Sales Market Share (%) in Japan (2012-2017)
    Figure AKORN Blood system drugs Revenue Market Share (%) in Japan (2012-2017)
    Table ALLERGAN SALES LLC Basic Information List
    Table ALLERGAN SALES LLC Blood system drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
    Table ALLERGAN SALES LLC Blood system drugs Sales Growth Rate (%)(2012-2017)
    Table ALLERGAN SALES LLC Blood system drugs Sales Market Share (%) in Japan (2012-2017)
    Figure ALLERGAN SALES LLC Blood system drugs Revenue Market Share (%) in Japan (2012-2017)
    Table AMNEAL PHARMS Basic Information List
    Table AMNEAL PHARMS Blood system drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
    Table AMNEAL PHARMS Blood system drugs Sales Growth Rate (%)(2012-2017)
    Table AMNEAL PHARMS Blood system drugs Sales Market Share (%) in Japan (2012-2017)
    Figure AMNEAL PHARMS Blood system drugs Revenue Market Share (%) in Japan (2012-2017)
    Table APOTEX Basic Information List
    Table APOTEX Blood system drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
    Table APOTEX Blood system drugs Sales Growth Rate (%)(2012-2017)
    Table APOTEX Blood system drugs Sales Market Share (%) in Japan (2012-2017)
    Figure APOTEX Blood system drugs Revenue Market Share (%) in Japan (2012-2017)
    Table ARALEZ PHARMS Basic Information List
    Table ARALEZ PHARMS Blood system drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
    Table ARALEZ PHARMS Blood system drugs Sales Growth Rate (%)(2012-2017)
    Table ARALEZ PHARMS Blood system drugs Sales Market Share (%) in Japan (2012-2017)
    Figure ARALEZ PHARMS Blood system drugs Revenue Market Share (%) in Japan (2012-2017)
    Table ASTRAZENECA PHARMS Basic Information List
    Table ASTRAZENECA PHARMS Blood system drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
    Table ASTRAZENECA PHARMS Blood system drugs Sales Growth Rate (%)(2012-2017)
    Table ASTRAZENECA PHARMS Blood system drugs Sales Market Share (%) in Japan (2012-2017)
    Figure ASTRAZENECA PHARMS Blood system drugs Revenue Market Share (%) in Japan (2012-2017)
    Table AVEDRO INC Basic Information List
    Table AVEDRO INC Blood system drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
    Table AVEDRO INC Blood system drugs Sales Growth Rate (%)(2012-2017)
    Table AVEDRO INC Blood system drugs Sales Market Share (%) in Japan (2012-2017)
    Figure AVEDRO INC Blood system drugs Revenue Market Share (%) in Japan (2012-2017)
    Table BARR Basic Information List
    Table BARR Blood system drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
    Table BARR Blood system drugs Sales Growth Rate (%)(2012-2017)
    Table BARR Blood system drugs Sales Market Share (%) in Japan (2012-2017)
    Figure BARR Blood system drugs Revenue Market Share (%) in Japan (2012-2017)
    Table BAXTER HLTHCARE Basic Information List
    Table BAXTER HLTHCARE Blood system drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
    Table BAXTER HLTHCARE Blood system drugs Sales Growth Rate (%)(2012-2017)
    Table BAXTER HLTHCARE Blood system drugs Sales Market Share (%) in Japan (2012-2017)
    Figure BAXTER HLTHCARE Blood system drugs Revenue Market Share (%) in Japan (2012-2017)
    Table BIOKEY Basic Information List
    Table BRECKENRIDGE PHARM Basic Information List
    Table BRISTOL MYERS SQUIBB Basic Information List
    Table CHIESI USA INC Basic Information List
    Table CLOVER PHARMS Basic Information List
    Table EMCURE PHARMS LTD Basic Information List
    Table FERRING PHARMS INC Basic Information List
    Table FRESENIUS KABI USA Basic Information List
    Table GENENTECH Basic Information List
    Table GLAND PHARMA LTD Basic Information List
    Table GLENMARK PHARMS LTD Basic Information List
    Table HERITAGE PHARMA Basic Information List
    Table HOSPIRA Basic Information List
    Table INVAGEN PHARMS Basic Information List
    Table IPCA LABS LTD Basic Information List
    Table LUITPOLD Basic Information List
    Table MEDICURE Basic Information List
    Table MYLAN Basic Information List
    Table NEW RIVER Basic Information List
    Table PFIZER Basic Information List
    Table Production Base and Market Concentration Rate of Raw Material
    Figure Price Trend of Key Raw Materials
    Table Key Suppliers of Raw Materials
    Figure Manufacturing Cost Structure of Blood system drugs
    Figure Manufacturing Process Analysis of Blood system drugs
    Figure Blood system drugs Industrial Chain Analysis
    Table Raw Materials Sources of Blood system drugs Major Players/Manufacturers in 2016
    Table Major Buyers of Blood system drugs
    Table Distributors/Traders List
    Figure Japan Blood system drugs Sales () and Growth Rate (%) Forecast (2017-2022)
    Figure Japan Blood system drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
    Figure Japan Blood system drugs Price () Trend Forecast (2017-2022)
    Figure Global Blood system drugs Sales () and Growth Rate (%) Forecast (2017-2022)
    Figure Global Blood system drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
    Figure Global Blood system drugs Price () Trend Forecast (2017-2022)
    Table Japan Blood system drugs Sales () Forecast by Type (2017-2022)
    Table Global Blood system drugs Sales () Forecast by Type (2017-2022)
    Figure Japan Blood system drugs Sales () Forecast by Type (2017-2022)
    Figure Global Blood system drugs Sales () Forecast by Type (2017-2022)
    Figure Japan Blood system drugs Sales Volume Market Share Forecast by Type in 2017
    Figure Global Blood system drugs Sales Volume Market Share Forecast by Type in 2017
    Table Japan Blood system drugs Sales () Forecast by Application (2017-2022)
    Figure Japan Blood system drugs Sales Volume Market Share Forecast by Application (2017-2022)
    Figure Japan Blood system drugs Sales Volume Market Share Forecast by Application in 2017
    Table Global Blood system drugs Sales () Forecast by Application (2017-2022)
    Figure Global Blood system drugs Sales Volume Market Share Forecast by Application (2017-2022)
    Figure Global Blood system drugs Sales Volume Market Share Forecast by Application in 2017
    Table Japan Blood system drugs Sales () Forecast by Regions (2017-2022)
    Table Japan Blood system drugs Sales Volume Share Forecast by Regions (2017-2022)
    Figure Japan Blood system drugs Sales Volume Share Forecast by Regions (2017-2022)
    Table Global Blood system drugs Sales () Forecast by Regions (2017-2022)
    Table Global Blood system drugs Sales Volume Share Forecast by Regions (2017-2022)
    Figure Global Blood system drugs Sales Volume Share Forecast by Regions (2017-2022)
    Table Research Programs/Design for This Report
    Figure Bottom-up and Top-down Approaches for This Report
    Figure Data Triangulation
    Table Key Data Information from Secondary Sources
    Table Key Data Information from Primary Sources